C4 Therapeutics Inc (CCCC)
1.1300 x 6 1.3200 x 3
Pre-market by (Cboe BZX)
1.2050 -0.1250 (-9.40%) 04/08/25 [NASDAQ]
1.1300 x 6 1.3200 x 3
Pre-market 1.2000 -0.0050 (-0.41%) 04:02 ET
for Tue, Apr 8th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,316 | -132,493 | -128,175 | -83,892 | -66,335 |
| Depreciation Amortization | -3,578 | -1,499 | 3,103 | 4,090 | 1,931 |
| Accounts receivable | 8,697 | -10,327 | 4,244 | -1,232 | 139 |
| Accounts payable and accrued liabilities | -119 | 273 | -3,333 | -1,179 | 467 |
| Other Working Capital | 7,648 | -6,938 | -16,779 | -30,090 | -13,177 |
| Other Operating Activity | 27,511 | 44,146 | 35,001 | 25,338 | 9,726 |
| Operating Cash Flow | $-65,157 | $-106,838 | $-105,939 | $-86,965 | $-67,249 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -51,090 | 160,057 | -219,527 | -188,059 | -189,855 |
| PPE Investments | -180 | -1,708 | -5,496 | -1,277 | -650 |
| Sale Of Investment | N/A | N/A | 283,445 | N/A | N/A |
| Investing Cash Flow | $-51,270 | $158,349 | $58,422 | $-189,336 | $-190,505 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 11,973 |
| Debt Repayment | N/A | -12,500 | N/A | N/A | N/A |
| Common Stock Issued | 45,148 | 57,731 | 777 | 171,795 | 195,961 |
| Common Stock Repurchased | -194 | -110 | 0 | N/A | -921 |
| Other Financing Activity | 382 | 368 | 370 | -395 | 141,919 |
| Financing Cash Flow | $45,336 | $45,489 | $1,147 | $171,400 | $348,932 |
| Beginning Cash Position | 130,033 | 33,033 | 79,403 | 184,304 | 93,126 |
| End Cash Position | 58,942 | 130,033 | 33,033 | 79,403 | 184,304 |
| Net Cash Flow | $-71,091 | $97,000 | $-46,370 | $-104,901 | $91,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,157 | -106,838 | -105,939 | -86,965 | -67,249 |
| Capital Expenditure | -180 | -1,708 | -5,496 | -1,277 | -650 |
| Free Cash Flow | -65,337 | -108,546 | -111,435 | -88,242 | -67,899 |